Anna Chiu

1.1k total citations · 1 hit paper
15 papers, 542 citations indexed

About

Anna Chiu is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Anna Chiu has authored 15 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 3 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Anna Chiu's work include Antimicrobial Resistance in Staphylococcus (5 papers), HIV Research and Treatment (3 papers) and Streptococcal Infections and Treatments (3 papers). Anna Chiu is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (5 papers), HIV Research and Treatment (3 papers) and Streptococcal Infections and Treatments (3 papers). Anna Chiu collaborates with scholars based in United States, Canada and United Kingdom. Anna Chiu's co-authors include Lisa Burry, Andrew M. Morris, Chaim M. Bell, Eshan Fernando, Marilyn Steinberg, Sumit Raybardhan, Michelle Science, Adrienne Showler, Anthony D. Bai and Daniel Ricciuto and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Clinical Infectious Diseases.

In The Last Decade

Anna Chiu

15 papers receiving 520 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study

2025 14 citations John Ling, Anna Chiu et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Chiu United States	11	261	156	155	105	74	15	542
Shungo Yamamoto Japan	12	54 0.2×	31 0.2×	123 0.8×	42 0.4×	40 0.5×	33	373
Marvin A. H. Berrevoets Netherlands	13	92 0.4×	44 0.3×	166 1.1×	71 0.7×	74 1.0×	33	494
Mimi Lou United States	13	146 0.6×	84 0.5×	88 0.6×	59 0.6×	28 0.4×	37	569
Élisa Demonchy France	12	143 0.5×	34 0.2×	147 0.9×	34 0.3×	64 0.9×	36	360
Jongtak Jung South Korea	12	258 1.0×	45 0.3×	133 0.9×	36 0.3×	31 0.4×	38	541
Emily A. Thorell United States	15	156 0.6×	60 0.4×	220 1.4×	88 0.8×	84 1.1×	33	516
Eshan Fernando Canada	6	214 0.8×	149 1.0×	149 1.0×	106 1.0×	71 1.0×	6	376
Katryn Paquette Canada	12	186 0.7×	95 0.6×	187 1.2×	91 0.9×	32 0.4×	19	577
Nisha Andany Canada	11	166 0.6×	16 0.1×	80 0.5×	74 0.7×	24 0.3×	35	484
Torsten T. Bauer Germany	14	53 0.2×	24 0.2×	179 1.2×	32 0.3×	24 0.3×	37	629

Countries citing papers authored by Anna Chiu

Since Specialization

Citations

This map shows the geographic impact of Anna Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Chiu more than expected).

Fields of papers citing papers by Anna Chiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Chiu. The network helps show where Anna Chiu may publish in the future.

Co-authorship network of co-authors of Anna Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Chiu. A scholar is included among the top collaborators of Anna Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Chiu. Anna Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Ling, John, et al.. (2025). Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study. The Lancet. 405(10485). 1147–1154. 14 indexed citations breakdown →

Zheng, Jim, Bing Lu, Gavin Carr, et al.. (2024). Lenacapavir Exhibits Atropisomerism—Mechanistic Pharmacokinetics and Disposition Studies of Lenacapavir Reveal Intestinal Excretion as a Major Clearance Pathway. Journal of Pharmacology and Experimental Therapeutics. 391(1). 91–103. 6 indexed citations

Chiu, Anna, et al.. (2023). Detecting Hate Speech on Social Media with Respect to Adolescent Vulnerability. 724–728. 2 indexed citations

Subramanian, Raju, Jennifer Tang, Jim Zheng, et al.. (2023). Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral Agent. Molecular Pharmaceutics. 20(12). 6213–6225. 27 indexed citations

Zheng, Jim, Stephen R. Yant, Shekeba Ahmadyar, et al.. (2018). 539. GS-CA2: A Novel, Potent, and Selective First-In-class Inhibitor of HIV-1 Capsid Function Displays Nonclinical Pharmacokinetics Supporting Long-Acting Potential in Humans. Open Forum Infectious Diseases. 5(suppl_1). S199–S200. 12 indexed citations

Bai, Anthony D., Adrienne Showler, Lisa Burry, et al.. (2017). Staphylococcus aureus bacteremia in immunosuppressed patients: a multicenter, retrospective cohort study. European Journal of Clinical Microbiology & Infectious Diseases. 36(7). 1231–1241. 19 indexed citations

Bai, Anthony D., Lisa Burry, Adrienne Showler, et al.. (2015). Usefulness of Previous Methicillin‐resistant Staphylococcus aureus Screening Results in Guiding Empirical Therapy for S Aureus Bacteremia. Canadian Journal of Infectious Diseases and Medical Microbiology. 26(4). 201–206. 7 indexed citations

Bai, Anthony D., Adrienne Showler, Lisa Burry, et al.. (2015). Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study. Clinical Infectious Diseases. 60(10). 1451–1461. 196 indexed citations

Showler, Adrienne, Lisa Burry, Anthony D. Bai, et al.. (2015). Use of Transthoracic Echocardiography in the Management of Low-Risk Staphylococcus aureus Bacteremia. JACC. Cardiovascular imaging. 8(8). 924–931. 24 indexed citations

10.

Bai, Anthony D., Adrienne Showler, Lisa Burry, et al.. (2015). Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study. Journal of Antimicrobial Chemotherapy. 70(5). 1539–1546. 65 indexed citations

11.

Chiu, Anna, et al.. (2007). Lamotrigine-Induced Blood Dyscrasias in Association with Rash. The Canadian Journal of Hospital Pharmacy. 60(4). 1 indexed citations

12.

Dong, Xiao, Weixing Wang, Lixin Xie, & Anna Chiu. (2005). Long-term outcome of combined penetrating keratoplasty and vitreoretinal surgery using temporary keratoprosthesis. Eye. 20(1). 59–63. 29 indexed citations

13.

Chu, Leung‐Wing, et al.. (2001). A Randomized Controlled Trial of Low-Dose Recombinant Human Growth Hormone in the Treatment of Malnourished Elderly Medical Patients¹. The Journal of Clinical Endocrinology & Metabolism. 86(5). 1913–1920. 36 indexed citations

14.

Chu, Leung‐Wing, et al.. (1999). Risk Factors for Falls in Hospitalized Older Medical Patients. The Journals of Gerontology Series A. 54(1). M38–M43. 68 indexed citations

15.

Zighelboim, Jacob, et al.. (1974). Antibody dependent cellular cytotoxicity: Cytotoxicity mediated by non T-lymphocytes. Clinical Immunology and Immunopathology. 3(2). 193–200. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact